Kohlberg Kravis Roberts & Co. L.P. Bausch Health Companies Inc. Transaction History
Kohlberg Kravis Roberts & Co. L.P.
- $2.49 Billion
- Q3 2025
A detailed history of Kohlberg Kravis Roberts & Co. L.P. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Kohlberg Kravis Roberts & Co. L.P. holds 5,235,000 shares of BHC stock, worth $32.9 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
5,235,000
Previous 5,235,000
-0.0%
Holding current value
$32.9 Million
Previous $34.9 Million
3.16%
% of portfolio
1.36%
Previous 1.38%
Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
262Shares Held
207MCall Options Held
2.54MPut Options Held
6.46M-
John Paulson Paulson & Co. Inc. | New York, Ny70.8MShares$444 Million16.32% of portfolio
-
Nomura Holdings Inc Tokyo, M015.7MShares$98.6 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$81.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$76.9 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A610.5MShares$66 Million0.01% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.27B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...